Today, Rescuing Biomedical Research submitted a response to the National Institutes of Health’s request for information regarding the use of preprints and other interim research products in grant review. We strongly support the ASAPbio position in this regard, and our response is highly similar to the ASAPbio response to the RFI.
From the response:
A strong NIH policy concerning preprints will have far-reaching consequences. The development of NIH-endorsed standards for preprints will be critical for their acceptance by the biomedical research community; increased adoption of preprints will benefit both scientists and the research process.
Read the full RBR response here.